Matthew Elias, DO
Dermatology · Fort Lauderdale, FLNPI 1114118163
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $129,700 of the $210,428 with a category attached, or 61.6%. AbbVie accounts for 87.5% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2023 at $64,245 and has fallen 66.5% since, to $21,528 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,020 payments — averaging $206.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$184K
- Merz North America, Inc.$5K
- Dermavant Sciences, Inc.$3K
- Galderma Laboratories, L.p.$2K
- Johnson & Johnson$2K
- EPI Health, LLC$2K
- plus $13K from 31 others
What the payments were for
- Consulting fees$39,88219%
- Speaking & faculty fees$129,70062%
- Travel & lodging$19,5739%
- Food & beverage$20,49410%
- Education$7800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$5,169
- BOTOX$3,213
- VTAMA$2,668
- WYNZORA$1,500
- Kerecis GraftGuide$1,292
- Klisyri$800
- DUPIXENT$483
- AMELUZ$475
- BF-RhodoLED$475
- XEPI$475
- Skyrizi$387
- InnovaMatrix AC$242
- COSENTYX$241
- CIBINQO$227
- ILUMYA$149
- SILIQ$136
- NEMLUVIO$134
- Bimzelx$127
- DAXXIFY$126
- Rhapsido$121
How this compares
$210,428 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 18 | $380,519 |
| Dupixent PenDupilumab | 11 | $39,062 |
| Ketoconazole | 242 | $4,450 |
| Triamcinolone Acetonide | 214 | $3,226 |
| Clobetasol Propionate | 52 | $1,617 |
| Fluocinonide | 40 | $1,194 |
| Hydrocortisone | 104 | $711 |
| Gentamicin Sulfate | 18 | $702 |
| Fluorouracil | 17 | $594 |
| Clindamycin Phosphate | 21 | $512 |
| Mupirocin | 77 | $465 |
| Metronidazole | 12 | $408 |
| Imiquimod | 14 | $305 |
| ValacyclovirValacyclovir Hcl | 55 | $284 |
| Doxycycline Hyclate | 68 | $283 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Lauderdale
- Jason GreenFort Lauderdale$213K
- Jerome ObedFort Lauderdale$150K
- Willie RichardsonFort Lauderdale$124K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.